nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.137	0.583	CrCrCtD
Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	0.132	1	CbGaD
Dextropropoxyphene—Quinapril—Ramipril—type 2 diabetes mellitus	0.0979	0.417	CrCrCtD
Dextropropoxyphene—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0275	0.0614	CbGbCtD
Dextropropoxyphene—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.022	0.0491	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0209	0.0467	CbGbCtD
Dextropropoxyphene—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0209	0.0467	CbGbCtD
Dextropropoxyphene—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0199	0.0444	CbGbCtD
Dextropropoxyphene—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0192	0.0428	CbGbCtD
Dextropropoxyphene—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0183	0.041	CbGbCtD
Dextropropoxyphene—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0177	0.0396	CbGbCtD
Dextropropoxyphene—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0175	0.0392	CbGbCtD
Dextropropoxyphene—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0163	0.0364	CbGbCtD
Dextropropoxyphene—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0144	0.0323	CbGbCtD
Dextropropoxyphene—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0138	0.031	CbGbCtD
Dextropropoxyphene—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0138	0.031	CbGbCtD
Dextropropoxyphene—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0128	0.0286	CbGbCtD
Dextropropoxyphene—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0127	0.0283	CbGbCtD
Dextropropoxyphene—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0125	0.028	CbGbCtD
Dextropropoxyphene—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0123	0.0276	CbGbCtD
Dextropropoxyphene—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0117	0.0261	CbGbCtD
Dextropropoxyphene—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0113	0.0253	CbGbCtD
Dextropropoxyphene—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0111	0.0249	CbGbCtD
Dextropropoxyphene—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0105	0.0235	CbGbCtD
Dextropropoxyphene—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0102	0.0228	CbGbCtD
Dextropropoxyphene—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0101	0.0225	CbGbCtD
Dextropropoxyphene—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0096	0.0215	CbGbCtD
Dextropropoxyphene—CYP2C8—Losartan—type 2 diabetes mellitus	0.0093	0.0208	CbGbCtD
Dextropropoxyphene—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0092	0.0206	CbGbCtD
Dextropropoxyphene—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0089	0.0199	CbGbCtD
Dextropropoxyphene—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00805	0.018	CbGbCtD
Dextropropoxyphene—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00709	0.0159	CbGbCtD
Dextropropoxyphene—CYP2C9—Losartan—type 2 diabetes mellitus	0.00648	0.0145	CbGbCtD
Dextropropoxyphene—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0061	0.0137	CbGbCtD
Dextropropoxyphene—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00585	0.0131	CbGbCtD
Dextropropoxyphene—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00585	0.0131	CbGbCtD
Dextropropoxyphene—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00553	0.0124	CbGbCtD
Dextropropoxyphene—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00412	0.00922	CbGbCtD
Dextropropoxyphene—CYP3A4—Losartan—type 2 diabetes mellitus	0.00377	0.00843	CbGbCtD
Dextropropoxyphene—Bepridil—KCNQ1—type 2 diabetes mellitus	0.00052	0.166	CrCbGaD
Dextropropoxyphene—Bepridil—CALM1—type 2 diabetes mellitus	0.000248	0.0789	CrCbGaD
Dextropropoxyphene—Loperamide—CALM1—type 2 diabetes mellitus	0.00022	0.0699	CrCbGaD
Dextropropoxyphene—Quinapril—ACE—type 2 diabetes mellitus	0.000209	0.0666	CrCbGaD
Dextropropoxyphene—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000193	0.0615	CrCbGaD
Dextropropoxyphene—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000167	0.00124	CcSEcCtD
Dextropropoxyphene—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000167	0.00124	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00123	CcSEcCtD
Dextropropoxyphene—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000165	0.00122	CcSEcCtD
Dextropropoxyphene—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000164	0.00122	CcSEcCtD
Dextropropoxyphene—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00122	CcSEcCtD
Dextropropoxyphene—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000164	0.00122	CcSEcCtD
Dextropropoxyphene—Hypotension—Glyburide—type 2 diabetes mellitus	0.000164	0.00122	CcSEcCtD
Dextropropoxyphene—Nausea—Repaglinide—type 2 diabetes mellitus	0.000164	0.00121	CcSEcCtD
Dextropropoxyphene—Asthenia—Glipizide—type 2 diabetes mellitus	0.000163	0.00121	CcSEcCtD
Dextropropoxyphene—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000163	0.00121	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.0012	CcSEcCtD
Dextropropoxyphene—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000162	0.0012	CcSEcCtD
Dextropropoxyphene—Malnutrition—Metformin—type 2 diabetes mellitus	0.000161	0.0012	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000161	0.00119	CcSEcCtD
Dextropropoxyphene—Syncope—Valsartan—type 2 diabetes mellitus	0.000159	0.00118	CcSEcCtD
Dextropropoxyphene—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000159	0.00118	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00117	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00117	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00117	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00116	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000157	0.00116	CcSEcCtD
Dextropropoxyphene—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000157	0.00116	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000156	0.00116	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000155	0.00115	CcSEcCtD
Dextropropoxyphene—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000155	0.00115	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000154	0.00115	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000154	0.00114	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000154	0.00114	CcSEcCtD
Dextropropoxyphene—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000154	0.00114	CcSEcCtD
Dextropropoxyphene—Jaundice—Ramipril—type 2 diabetes mellitus	0.000153	0.00114	CcSEcCtD
Dextropropoxyphene—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000153	0.00113	CcSEcCtD
Dextropropoxyphene—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Dextropropoxyphene—Vision blurred—Metformin—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Dextropropoxyphene—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Dextropropoxyphene—Convulsion—Orlistat—type 2 diabetes mellitus	0.000152	0.00113	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000152	0.00112	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000151	0.00112	CcSEcCtD
Dextropropoxyphene—Dizziness—Glipizide—type 2 diabetes mellitus	0.000151	0.00112	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000149	0.00111	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Dextropropoxyphene—Discomfort—Orlistat—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Dextropropoxyphene—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000147	0.00109	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000145	0.00108	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000145	0.00108	CcSEcCtD
Dextropropoxyphene—Vomiting—Glipizide—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Dextropropoxyphene—Syncope—Metformin—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000145	0.00107	CcSEcCtD
Dextropropoxyphene—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000144	0.00107	CcSEcCtD
Dextropropoxyphene—Rash—Glipizide—type 2 diabetes mellitus	0.000144	0.00107	CcSEcCtD
Dextropropoxyphene—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Dextropropoxyphene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Dextropropoxyphene—Headache—Glipizide—type 2 diabetes mellitus	0.000143	0.00106	CcSEcCtD
Dextropropoxyphene—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000142	0.00106	CcSEcCtD
Dextropropoxyphene—Shock—Valsartan—type 2 diabetes mellitus	0.000142	0.00106	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000142	0.00105	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000142	0.00105	CcSEcCtD
Dextropropoxyphene—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000141	0.00104	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Dextropropoxyphene—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Dextropropoxyphene—Agitation—Irbesartan—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Dextropropoxyphene—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00014	0.00104	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000139	0.00103	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000139	0.00103	CcSEcCtD
Dextropropoxyphene—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00102	CcSEcCtD
Dextropropoxyphene—Headache—Pioglitazone—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Dextropropoxyphene—Syncope—Irbesartan—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Dextropropoxyphene—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000136	0.00101	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000136	0.00101	CcSEcCtD
Dextropropoxyphene—Discomfort—Metformin—type 2 diabetes mellitus	0.000136	0.00101	CcSEcCtD
Dextropropoxyphene—Nausea—Glipizide—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Dextropropoxyphene—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Dextropropoxyphene—Hypotension—Valsartan—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Dextropropoxyphene—Vision blurred—Losartan—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Dextropropoxyphene—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000135	0.001	CcSEcCtD
Dextropropoxyphene—Constipation—Gliclazide—type 2 diabetes mellitus	0.000135	0.000999	CcSEcCtD
Dextropropoxyphene—Rash—Glimepiride—type 2 diabetes mellitus	0.000134	0.000994	CcSEcCtD
Dextropropoxyphene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000134	0.000993	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000134	0.000993	CcSEcCtD
Dextropropoxyphene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000134	0.000991	CcSEcCtD
Dextropropoxyphene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00099	CcSEcCtD
Dextropropoxyphene—Headache—Glimepiride—type 2 diabetes mellitus	0.000133	0.000988	CcSEcCtD
Dextropropoxyphene—Headache—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000985	CcSEcCtD
Dextropropoxyphene—Agitation—Losartan—type 2 diabetes mellitus	0.000132	0.000977	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000973	CcSEcCtD
Dextropropoxyphene—Insomnia—Valsartan—type 2 diabetes mellitus	0.000131	0.00097	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00013	0.000962	CcSEcCtD
Dextropropoxyphene—Shock—Metformin—type 2 diabetes mellitus	0.00013	0.000961	CcSEcCtD
Dextropropoxyphene—Insomnia—Orlistat—type 2 diabetes mellitus	0.000129	0.000959	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000129	0.000958	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000129	0.000958	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000129	0.000957	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000129	0.000955	CcSEcCtD
Dextropropoxyphene—Somnolence—Valsartan—type 2 diabetes mellitus	0.000129	0.000954	CcSEcCtD
Dextropropoxyphene—Syncope—Losartan—type 2 diabetes mellitus	0.000129	0.000954	CcSEcCtD
Dextropropoxyphene—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000128	0.00095	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.000946	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000127	0.000944	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000944	CcSEcCtD
Dextropropoxyphene—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000941	CcSEcCtD
Dextropropoxyphene—Nausea—Glimepiride—type 2 diabetes mellitus	0.000126	0.000937	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000126	0.000936	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000126	0.000935	CcSEcCtD
Dextropropoxyphene—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000126	0.000934	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000126	0.000933	CcSEcCtD
Dextropropoxyphene—Asthenia—Glyburide—type 2 diabetes mellitus	0.000126	0.000933	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000125	0.000926	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000923	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP1A2—type 2 diabetes mellitus	0.000124	0.0395	CrCbGaD
Dextropropoxyphene—Constipation—Valsartan—type 2 diabetes mellitus	0.000124	0.000918	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000123	0.000915	CcSEcCtD
Dextropropoxyphene—Hypotension—Metformin—type 2 diabetes mellitus	0.000123	0.000913	CcSEcCtD
Dextropropoxyphene—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000123	0.000912	CcSEcCtD
Dextropropoxyphene—Shock—Irbesartan—type 2 diabetes mellitus	0.000122	0.000907	CcSEcCtD
Dextropropoxyphene—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000122	0.000905	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.000904	CcSEcCtD
Dextropropoxyphene—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000121	0.0009	CcSEcCtD
Dextropropoxyphene—Rash—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000897	CcSEcCtD
Dextropropoxyphene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000896	CcSEcCtD
Dextropropoxyphene—Discomfort—Losartan—type 2 diabetes mellitus	0.000121	0.000894	CcSEcCtD
Dextropropoxyphene—Headache—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000891	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00012	0.00089	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.000877	CcSEcCtD
Dextropropoxyphene—Confusional state—Losartan—type 2 diabetes mellitus	0.000118	0.000875	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000118	0.000874	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000117	0.000871	CcSEcCtD
Dextropropoxyphene—Somnolence—Metformin—type 2 diabetes mellitus	0.000117	0.000869	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000867	CcSEcCtD
Dextropropoxyphene—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000116	0.000862	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000116	0.00086	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000116	0.00086	CcSEcCtD
Dextropropoxyphene—Shock—Losartan—type 2 diabetes mellitus	0.000115	0.000854	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000115	0.000851	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000848	CcSEcCtD
Dextropropoxyphene—Tachycardia—Losartan—type 2 diabetes mellitus	0.000114	0.000847	CcSEcCtD
Dextropropoxyphene—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000845	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000114	0.000844	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000838	CcSEcCtD
Dextropropoxyphene—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000838	CcSEcCtD
Dextropropoxyphene—Agitation—Ramipril—type 2 diabetes mellitus	0.000113	0.000838	CcSEcCtD
Dextropropoxyphene—Constipation—Metformin—type 2 diabetes mellitus	0.000113	0.000836	CcSEcCtD
Dextropropoxyphene—Vomiting—Glyburide—type 2 diabetes mellitus	0.000111	0.000827	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000822	CcSEcCtD
Dextropropoxyphene—Rash—Glyburide—type 2 diabetes mellitus	0.000111	0.00082	CcSEcCtD
Dextropropoxyphene—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000111	0.00082	CcSEcCtD
Dextropropoxyphene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00011	0.000819	CcSEcCtD
Dextropropoxyphene—Syncope—Ramipril—type 2 diabetes mellitus	0.00011	0.000818	CcSEcCtD
Dextropropoxyphene—Headache—Glyburide—type 2 diabetes mellitus	0.00011	0.000815	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000812	CcSEcCtD
Dextropropoxyphene—Hypotension—Losartan—type 2 diabetes mellitus	0.000109	0.000811	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000109	0.000805	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000108	0.000801	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000108	0.000799	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000108	0.000799	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000107	0.000796	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000107	0.000791	CcSEcCtD
Dextropropoxyphene—Convulsion—Ramipril—type 2 diabetes mellitus	0.000107	0.00079	CcSEcCtD
Dextropropoxyphene—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.000789	CcSEcCtD
Dextropropoxyphene—Insomnia—Losartan—type 2 diabetes mellitus	0.000106	0.000785	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000105	0.000781	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000104	0.000774	CcSEcCtD
Dextropropoxyphene—Nausea—Glyburide—type 2 diabetes mellitus	0.000104	0.000773	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000772	CcSEcCtD
Dextropropoxyphene—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000104	0.000772	CcSEcCtD
Dextropropoxyphene—Somnolence—Losartan—type 2 diabetes mellitus	0.000104	0.000771	CcSEcCtD
Dextropropoxyphene—Asthenia—Valsartan—type 2 diabetes mellitus	0.000104	0.00077	CcSEcCtD
Dextropropoxyphene—Discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.000767	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000103	0.000764	CcSEcCtD
Dextropropoxyphene—Asthenia—Orlistat—type 2 diabetes mellitus	0.000103	0.000761	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.00076	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.000754	CcSEcCtD
Dextropropoxyphene—Confusional state—Ramipril—type 2 diabetes mellitus	0.000101	0.00075	CcSEcCtD
Dextropropoxyphene—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0001	0.000743	CcSEcCtD
Dextropropoxyphene—Constipation—Losartan—type 2 diabetes mellitus	0.0001	0.000742	CcSEcCtD
Dextropropoxyphene—Rash—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.000736	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.92e-05	0.000736	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.9e-05	0.000734	CcSEcCtD
Dextropropoxyphene—Shock—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000732	CcSEcCtD
Dextropropoxyphene—Headache—Gliclazide—type 2 diabetes mellitus	9.86e-05	0.000732	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.84e-05	0.00073	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.83e-05	0.000729	CcSEcCtD
Dextropropoxyphene—Tachycardia—Ramipril—type 2 diabetes mellitus	9.79e-05	0.000726	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000725	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.64e-05	0.000715	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.57e-05	0.00071	CcSEcCtD
Dextropropoxyphene—Dizziness—Valsartan—type 2 diabetes mellitus	9.57e-05	0.00071	CcSEcCtD
Dextropropoxyphene—Dizziness—Orlistat—type 2 diabetes mellitus	9.45e-05	0.000701	CcSEcCtD
Dextropropoxyphene—Asthenia—Metformin—type 2 diabetes mellitus	9.45e-05	0.000701	CcSEcCtD
Dextropropoxyphene—Hypotension—Ramipril—type 2 diabetes mellitus	9.37e-05	0.000695	CcSEcCtD
Dextropropoxyphene—Nausea—Gliclazide—type 2 diabetes mellitus	9.35e-05	0.000694	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Losartan—type 2 diabetes mellitus	9.25e-05	0.000686	CcSEcCtD
Dextropropoxyphene—Vomiting—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000682	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000679	CcSEcCtD
Dextropropoxyphene—Benzphetamine—ADRA2A—type 2 diabetes mellitus	9.14e-05	0.0291	CrCbGaD
Dextropropoxyphene—Rash—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000677	CcSEcCtD
Dextropropoxyphene—Dermatitis—Valsartan—type 2 diabetes mellitus	9.11e-05	0.000676	CcSEcCtD
Dextropropoxyphene—Vomiting—Orlistat—type 2 diabetes mellitus	9.09e-05	0.000674	CcSEcCtD
Dextropropoxyphene—Insomnia—Ramipril—type 2 diabetes mellitus	9.07e-05	0.000673	CcSEcCtD
Dextropropoxyphene—Headache—Valsartan—type 2 diabetes mellitus	9.06e-05	0.000672	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Metformin—type 2 diabetes mellitus	9.01e-05	0.000669	CcSEcCtD
Dextropropoxyphene—Rash—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000668	CcSEcCtD
Dextropropoxyphene—Dermatitis—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000668	CcSEcCtD
Dextropropoxyphene—Headache—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000664	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000663	CcSEcCtD
Dextropropoxyphene—Asthenia—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.000662	CcSEcCtD
Dextropropoxyphene—Somnolence—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000661	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.83e-05	0.000655	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP1A2—type 2 diabetes mellitus	8.74e-05	0.0278	CrCbGaD
Dextropropoxyphene—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	8.74e-05	0.0278	CrCbGaD
Dextropropoxyphene—Dizziness—Metformin—type 2 diabetes mellitus	8.71e-05	0.000646	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000642	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.62e-05	0.000639	CcSEcCtD
Dextropropoxyphene—Nausea—Valsartan—type 2 diabetes mellitus	8.59e-05	0.000637	CcSEcCtD
Dextropropoxyphene—Constipation—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000636	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000631	CcSEcCtD
Dextropropoxyphene—Nausea—Orlistat—type 2 diabetes mellitus	8.49e-05	0.00063	CcSEcCtD
Dextropropoxyphene—Asthenia—Losartan—type 2 diabetes mellitus	8.39e-05	0.000623	CcSEcCtD
Dextropropoxyphene—Vomiting—Metformin—type 2 diabetes mellitus	8.38e-05	0.000621	CcSEcCtD
Dextropropoxyphene—Rash—Metformin—type 2 diabetes mellitus	8.31e-05	0.000616	CcSEcCtD
Dextropropoxyphene—Dermatitis—Metformin—type 2 diabetes mellitus	8.3e-05	0.000615	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000613	CcSEcCtD
Dextropropoxyphene—Headache—Metformin—type 2 diabetes mellitus	8.25e-05	0.000612	CcSEcCtD
Dextropropoxyphene—Dizziness—Irbesartan—type 2 diabetes mellitus	8.22e-05	0.00061	CcSEcCtD
Dextropropoxyphene—Toremifene—CYP3A4—type 2 diabetes mellitus	8.21e-05	0.0261	CrCbGaD
Dextropropoxyphene—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.2e-05	0.000608	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Losartan—type 2 diabetes mellitus	8.01e-05	0.000594	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000588	CcSEcCtD
Dextropropoxyphene—Vomiting—Irbesartan—type 2 diabetes mellitus	7.91e-05	0.000586	CcSEcCtD
Dextropropoxyphene—Rash—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000581	CcSEcCtD
Dextropropoxyphene—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000581	CcSEcCtD
Dextropropoxyphene—Nausea—Metformin—type 2 diabetes mellitus	7.83e-05	0.00058	CcSEcCtD
Dextropropoxyphene—Headache—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000578	CcSEcCtD
Dextropropoxyphene—Dizziness—Losartan—type 2 diabetes mellitus	7.74e-05	0.000574	CcSEcCtD
Dextropropoxyphene—Alimemazine—CYP3A4—type 2 diabetes mellitus	7.71e-05	0.0245	CrCbGaD
Dextropropoxyphene—Trimipramine—ADRA2A—type 2 diabetes mellitus	7.46e-05	0.0238	CrCbGaD
Dextropropoxyphene—Vomiting—Losartan—type 2 diabetes mellitus	7.44e-05	0.000552	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCC2—type 2 diabetes mellitus	7.42e-05	0.0236	CrCbGaD
Dextropropoxyphene—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000548	CcSEcCtD
Dextropropoxyphene—Nausea—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000548	CcSEcCtD
Dextropropoxyphene—Rash—Losartan—type 2 diabetes mellitus	7.38e-05	0.000547	CcSEcCtD
Dextropropoxyphene—Dermatitis—Losartan—type 2 diabetes mellitus	7.37e-05	0.000547	CcSEcCtD
Dextropropoxyphene—Headache—Losartan—type 2 diabetes mellitus	7.33e-05	0.000544	CcSEcCtD
Dextropropoxyphene—Modafinil—CYP1A2—type 2 diabetes mellitus	7.33e-05	0.0233	CrCbGaD
Dextropropoxyphene—Asthenia—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000534	CcSEcCtD
Dextropropoxyphene—Nausea—Losartan—type 2 diabetes mellitus	6.95e-05	0.000515	CcSEcCtD
Dextropropoxyphene—Trimipramine—HTR2C—type 2 diabetes mellitus	6.87e-05	0.0219	CrCbGaD
Dextropropoxyphene—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000509	CcSEcCtD
Dextropropoxyphene—Disopyramide—CYP3A4—type 2 diabetes mellitus	6.81e-05	0.0217	CrCbGaD
Dextropropoxyphene—Dizziness—Ramipril—type 2 diabetes mellitus	6.63e-05	0.000492	CcSEcCtD
Dextropropoxyphene—Vomiting—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000473	CcSEcCtD
Dextropropoxyphene—Rash—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Dermatitis—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000469	CcSEcCtD
Dextropropoxyphene—Headache—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000466	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	6.19e-05	0.0197	CrCbGaD
Dextropropoxyphene—Phenylbutazone—PTGS2—type 2 diabetes mellitus	6.06e-05	0.0193	CrCbGaD
Dextropropoxyphene—Nausea—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000442	CcSEcCtD
Dextropropoxyphene—Propafenone—CYP3A4—type 2 diabetes mellitus	5.79e-05	0.0184	CrCbGaD
Dextropropoxyphene—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	5.55e-05	0.0177	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP2E1—type 2 diabetes mellitus	5.21e-05	0.0166	CrCbGaD
Dextropropoxyphene—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	5.09e-05	0.0162	CrCbGaD
Dextropropoxyphene—Orphenadrine—CYP2E1—type 2 diabetes mellitus	5.06e-05	0.0161	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP1A2—type 2 diabetes mellitus	4.96e-05	0.0158	CrCbGaD
Dextropropoxyphene—Methadone—CYP1A2—type 2 diabetes mellitus	4.91e-05	0.0156	CrCbGaD
Dextropropoxyphene—Modafinil—CYP3A4—type 2 diabetes mellitus	4.85e-05	0.0154	CrCbGaD
Dextropropoxyphene—Fentanyl—CYP3A4—type 2 diabetes mellitus	4.74e-05	0.0151	CrCbGaD
Dextropropoxyphene—Loperamide—CYP3A4—type 2 diabetes mellitus	4.57e-05	0.0145	CrCbGaD
Dextropropoxyphene—Benzphetamine—CYP3A4—type 2 diabetes mellitus	4.21e-05	0.0134	CrCbGaD
Dextropropoxyphene—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	4.02e-05	0.0128	CrCbGaD
Dextropropoxyphene—Trimipramine—CYP3A4—type 2 diabetes mellitus	3.43e-05	0.0109	CrCbGaD
Dextropropoxyphene—Tamoxifen—CYP3A4—type 2 diabetes mellitus	3.28e-05	0.0104	CrCbGaD
Dextropropoxyphene—Methadone—CYP3A4—type 2 diabetes mellitus	3.25e-05	0.0104	CrCbGaD
Dextropropoxyphene—Orphenadrine—CYP3A4—type 2 diabetes mellitus	3.19e-05	0.0101	CrCbGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	5.52e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.51e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.51e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.49e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.49e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.47e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.46e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.45e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.45e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.45e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.44e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.43e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.43e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.4e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.4e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	5.4e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.39e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.36e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.34e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.33e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.32e-06	0.00011	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.31e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.29e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.28e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.28e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	5.23e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	5.23e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.22e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.22e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.2e-06	0.000107	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.08e-06	0.000105	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.04e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.02e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.96e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.95e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.92e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.91e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.91e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.91e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.86e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.82e-06	9.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.82e-06	9.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.78e-06	9.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.77e-06	9.84e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.76e-06	9.82e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.73e-06	9.75e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.73e-06	9.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.71e-06	9.71e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.71e-06	9.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.7e-06	9.69e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.69e-06	9.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.67e-06	9.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.63e-06	9.53e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.58e-06	9.44e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.56e-06	9.4e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.55e-06	9.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.54e-06	9.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.54e-06	9.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.54e-06	9.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.54e-06	9.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.53e-06	9.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.51e-06	9.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.51e-06	9.29e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.49e-06	9.25e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.49e-06	9.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.49e-06	9.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.48e-06	9.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.48e-06	9.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.46e-06	9.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.44e-06	9.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.44e-06	9.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.43e-06	9.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.41e-06	9.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.41e-06	9.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.39e-06	9.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.37e-06	9e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.36e-06	8.97e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.33e-06	8.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.33e-06	8.92e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.31e-06	8.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.3e-06	8.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.3e-06	8.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.29e-06	8.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.29e-06	8.84e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.29e-06	8.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.26e-06	8.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.26e-06	8.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.2e-06	8.66e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.19e-06	8.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.18e-06	8.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.12e-06	8.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.12e-06	8.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.1e-06	8.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.06e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.05e-06	8.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.02e-06	8.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.02e-06	8.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4e-06	8.25e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4e-06	8.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4e-06	8.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.99e-06	8.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.99e-06	8.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.9e-06	8.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.89e-06	8.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.85e-06	7.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.8e-06	7.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.78e-06	7.79e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.77e-06	7.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.76e-06	7.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.76e-06	7.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.7e-06	7.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.7e-06	7.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.7e-06	7.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.7e-06	7.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.69e-06	7.61e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.68e-06	7.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.68e-06	7.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.67e-06	7.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.67e-06	7.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.65e-06	7.52e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.63e-06	7.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.63e-06	7.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.62e-06	7.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.61e-06	7.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.61e-06	7.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.61e-06	7.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.6e-06	7.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.59e-06	7.39e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.57e-06	7.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.53e-06	7.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.52e-06	7.26e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.51e-06	7.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.5e-06	7.22e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.5e-06	7.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.5e-06	7.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.48e-06	7.17e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.45e-06	7.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.44e-06	7.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.43e-06	7.07e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.43e-06	7.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.41e-06	7.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.4e-06	7.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.4e-06	7.01e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.4e-06	7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.38e-06	6.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.37e-06	6.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.34e-06	6.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.3e-06	6.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.29e-06	6.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.27e-06	6.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.26e-06	6.71e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.24e-06	6.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.24e-06	6.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.24e-06	6.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.21e-06	6.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.2e-06	6.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.18e-06	6.55e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.18e-06	6.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.17e-06	6.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.16e-06	6.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.15e-06	6.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.13e-06	6.46e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.13e-06	6.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.11e-06	6.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.08e-06	6.35e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.07e-06	6.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.03e-06	6.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.01e-06	6.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3e-06	6.17e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	6.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.96e-06	6.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.96e-06	6.1e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.95e-06	6.08e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.94e-06	6.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.93e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.93e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.88e-06	5.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.88e-06	5.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.86e-06	5.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.83e-06	5.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.82e-06	5.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.81e-06	5.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.81e-06	5.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.81e-06	5.78e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.8e-06	5.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.79e-06	5.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.77e-06	5.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.69e-06	5.55e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.69e-06	5.54e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.65e-06	5.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.59e-06	5.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	5.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	5.31e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.48e-06	5.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.46e-06	5.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.44e-06	5.02e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.42e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.42e-06	4.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.41e-06	4.97e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.41e-06	4.96e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.39e-06	4.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.38e-06	4.9e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.36e-06	4.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	4.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.31e-06	4.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.24e-06	4.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.21e-06	4.56e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.2e-06	4.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.19e-06	4.52e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.18e-06	4.48e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.16e-06	4.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.15e-06	4.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	4.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	4.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.1e-06	4.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.1e-06	4.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.09e-06	4.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.07e-06	4.26e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.99e-06	4.11e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.98e-06	4.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.95e-06	4.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-06	3.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.92e-06	3.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.89e-06	3.9e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.88e-06	3.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.85e-06	3.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.85e-06	3.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.84e-06	3.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	3.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.61e-06	3.31e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.58e-06	3.25e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.45e-06	2.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	2.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	2.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	2.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	2.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.72e-07	2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.64e-07	1.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.36e-07	1.31e-05	CbGpPWpGaD
